Published on
September 17, 2018
- 12:30 GMT
Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Lipodystrophy, Familial Partial, Date of ...
Patients with lipodystrophy have low levels of a human hormone called leptin, which plays a key role in regulating the break-down of fats and sugars in the body. This leads to loss of fat from under the skin and its build-up in places such as the liver and …
Distribution channels:
Healthcare & Pharmaceuticals Industry
